$CVM announced it is in the final stages for the launch of its 212-patient Confirmatory Registration Study for Multikine* (Leukocyte Interleukin, Injection) in newly diagnosed locally advanced head and neck cancer patients. https://finance.yahoo.com/news/cel-sci-initia...00000.html

#STOCKS #STOCKSTOBUY #INVESTORS #STOCKS #TRADER #CVM Charles DAvanzo